Enhanced blood conservation in primary coronary artery bypass surgery using heparin-bonded circuits with lower anticoagulation

被引:8
作者
Aldea, GS
Zhang, X
Memmolo, CA
Shapira, OM
Treanor, PR
Kupferschmid, JP
Lazar, HL
Shemin, RJ
机构
[1] Department of Cardiothoracic Surgery, Boston University, Medical Center, Boston, MA
[2] Department of Cardiothoracic Surgery, Boston University, Medical Center, Boston, MA 02118-2393
关键词
D O I
10.1111/j.1540-8191.1996.tb00018.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Despite many advances in blood conservation techniques, a significant proportion of patients undergoing primary coronary revascularization still require homologous transfusions. A comprehensive strategy to diminish perioperative blood loss was developed by integrating many individual components to create an improved blood conservation environment and was prospectively applied to 557 patients undergoing primary coronary artery bypass grafting (CABG) procedures performed in our medical center over a 14-month period. Methods: The first 455 patients were treated with conventional, nonheparin-bonded circuits (NHBCs) and full anticoagulation (activated clotting time [ACT] > 480 sec). We wanted to test the hypothesis of whether ''tip-to-tip'' heparin-bonded circuits (HBCs) used in conjunction with lower anticoagulation (ACT > 280 sec) when added to our current blood conservation environment can further enhance clinical outcomes. We prospectively applied this technique to a consecutive group of patients (n = 102). Results: Compared to patients treated with NHBCs, patients treated with HBCs had a significantly lower mediastinal and pleural chest tube output in the first 24 hours (683 +/- 561 mt vs 984 +/- 616 mt, p < 0.00001) were less likely to be transfused (52% vs 68.1%, p < 0.01) and had a lower exposure to different blood donor units (4.1 +/- 8.4 vs 9.3 +/- 10.3, p < 0.000003). There were no complications directly related to HBCs used in conjunction with lower anticoagulation. Morbidity and mortality rates were similar in both treatment groups. Conclusion: In summary, HBCs in conjunction with lower anticoagulation were safely applied in patients undergoing primary CABG with marked improvement in blood conservation, and should be considered for broader clinical use.
引用
收藏
页码:85 / 95
页数:11
相关论文
共 33 条
[1]   INFLUENCE OF BLOOD-FLOW AND THE EFFECT OF PROTAMINE ON THE THROMBORESISTANT PROPERTIES OF A COVALENTLY BONDED HEPARIN SURFACE [J].
ARNANDER, C ;
OLSSON, P ;
LARM, O .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1988, 22 (10) :859-868
[2]  
Belboul A, 1993, J Extra Corpor Technol, V25, P40
[3]   HEPARIN COATING REDUCES BLOOD-CELL ADHESION TO ARTERIAL FILTERS DURING CORONARY-BYPASS - A CLINICAL-STUDY [J].
BOROWIEC, JW ;
BYLOCK, A ;
VANDERLINDEN, J ;
THELIN, S .
ANNALS OF THORACIC SURGERY, 1993, 55 (06) :1540-1545
[4]   DOES APROTININ INCREASE THE MYOCARDIAL DAMAGE IN THE SETTING OF ISCHEMIA AND PRECONDITIONING [J].
BUKHARI, EA ;
KRUKENKAMP, IB ;
BURNS, PG ;
GAUDETTE, GR ;
SCHULMAN, JJ ;
ALFAGIH, MR ;
LEVITSKY, S .
ANNALS OF THORACIC SURGERY, 1995, 60 (02) :307-310
[5]  
CARDOSO PFG, 1991, J THORAC CARDIOV SUR, V101, P153
[6]   APROTININ THERAPY FOR REOPERATIVE MYOCARDIAL REVASCULARIZATION - A PLACEBO-CONTROLLED STUDY [J].
COSGROVE, DM ;
HERIC, B ;
LYTLE, BW ;
TAYLOR, PC ;
NOVOA, R ;
GOLDING, LAR ;
STEWART, RW ;
MCCARTHY, PM ;
LOOP, FD .
ANNALS OF THORACIC SURGERY, 1992, 54 (06) :1031-1038
[7]  
DAILY PO, 1994, J THORAC CARDIOV SUR, V108, P99
[8]   SURFACE-BOUND HEPARIN - PANACEA OR PERIL [J].
EDMUNDS, LH .
ANNALS OF THORACIC SURGERY, 1994, 58 (02) :285-286
[9]   IS THERE A PHASE OF HYPERCOAGULABILITY WHEN APROTININ IS USED IN CARDIAC-SURGERY [J].
FEINDT, P ;
SEYFERT, U ;
VOLKMER, I ;
HUWER, H ;
KALWEIT, G ;
GAMS, E .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1994, 8 (06) :308-313
[10]   EFFECTS OF HIGH-DOSE APROTININ ON RENAL-FUNCTION IN AORTOCORONARY BYPASS-GRAFTING [J].
FEINDT, PR ;
WALCHER, S ;
VOLKMER, I ;
KELLER, HE ;
STRAUB, U ;
HUWER, H ;
SEYFERT, UT ;
PETZOLD, T ;
GAMS, E .
ANNALS OF THORACIC SURGERY, 1995, 60 (04) :1076-1080